Clinical Trials Browser

Phase 1 × INDUSTRY × ascrinvacumab × Clear all

NCT01337050 2015-10-28

Asian Phase I Study Of PF-03446962

Phase 1 Completed

36 enrolled 24 charts

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms

NCT00557856 2015-10-19

A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors

Phase 1 Completed

70 enrolled 22 charts

Other solid neoplasm

Advanced Solid Tumors